ALLO
Price
$2.52
Change
-$0.04 (-1.56%)
Updated
Dec 7, 6:59 PM EST
83 days until earnings call
AVRO
Price
$1.39
Change
+$0.04 (+2.96%)
Updated
Dec 7, 6:59 PM EST
104 days until earnings call
Ad is loading...

Compare trend and price ALLO vs AVRO

Header iconALLO vs AVRO Comparison
Open Charts ALLO vs AVROBanner chart's image
Allogene Therapeutics
Price$2.52
Change-$0.04 (-1.56%)
Volume$1.3M
CapitalizationN/A
AVROBIO
Price$1.39
Change+$0.04 (+2.96%)
Volume$151.6K
CapitalizationN/A
View a ticker or compare two or three
ALLO vs AVRO Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
ALLO vs. AVRO commentary
Dec 07, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALLO is a StrongSell and AVRO is a Hold.

COMPARISON
Comparison
Dec 07, 2023
Stock price -- (ALLO: $2.56 vs. AVRO: $1.39)
Brand notoriety: ALLO and AVRO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALLO: 177% vs. AVRO: 46%
Market capitalization -- ALLO: $427.42M vs. AVRO: $55.72M
ALLO [@Biotechnology] is valued at $427.42M. AVRO’s [@Biotechnology] market capitalization is $55.72M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALLO’s FA Score shows that 0 FA rating(s) are green whileAVRO’s FA Score has 1 green FA rating(s).

  • ALLO’s FA Score: 0 green, 5 red.
  • AVRO’s FA Score: 1 green, 4 red.
According to our system of comparison, AVRO is a better buy in the long-term than ALLO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALLO’s TA Score shows that 3 TA indicator(s) are bullish while AVRO’s TA Score has 4 bullish TA indicator(s).

  • ALLO’s TA Score: 3 bullish, 5 bearish.
  • AVRO’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, both ALLO and AVRO are a bad buy in the short-term.

Price Growth

ALLO (@Biotechnology) experienced а +12.28% price change this week, while AVRO (@Biotechnology) price change was +5.30% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.16%. For the same industry, the average monthly price growth was +6.81%, and the average quarterly price growth was +25.31%.

Reported Earning Dates

ALLO is expected to report earnings on Feb 28, 2024.

AVRO is expected to report earnings on Mar 20, 2024.

Industries' Descriptions

@Biotechnology (+6.16% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for ALLO with price predictions.
OPEN
A.I.dvisor published
a Summary for AVRO with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
ALLO($427M) has a higher market cap than AVRO($55.7M). AVRO YTD gains are higher at: 94.978 vs. ALLO (-59.300). AVRO has higher annual earnings (EBITDA): -86.35M vs. ALLO (-325.15M). ALLO has more cash in the bank: 466M vs. AVRO (106M). AVRO has less debt than ALLO: AVRO (1.75M) vs ALLO (90.1M). ALLO has higher revenues than AVRO: ALLO (186K) vs AVRO (0).
ALLOAVROALLO / AVRO
Capitalization427M55.7M767%
EBITDA-325.15M-86.35M377%
Gain YTD-59.30094.978-62%
P/E RatioN/AN/A-
Revenue186K0-
Total Cash466M106M440%
Total Debt90.1M1.75M5,143%
TECHNICAL ANALYSIS
Technical Analysis
ALLOAVRO
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 3 days ago
82%
Declines
ODDS (%)
Bearish Trend 16 days ago
81%
Bearish Trend 9 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TBWAX16.440.03
+0.18%
Thornburg Better World International A
SPRAX21.04-0.01
-0.05%
PGIM Quant Solutions Mid-Cap Val A
AXVNX17.15-0.03
-0.16%
Acclivity Small Cap Value N
MFRKX54.20-0.20
-0.37%
MFS Research R6
ACFOX45.25-0.22
-0.48%
American Century Focused Dynamic Gr Inv